218 related articles for article (PubMed ID: 34013757)
21. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
Xiao W; Tormey CA; Capetillo A; Maitta RW
Vox Sang; 2013 Nov; 105(4):334-40. PubMed ID: 23802769
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
Slichter SJ; Davis K; Enright H; Braine H; Gernsheimer T; Kao KJ; Kickler T; Lee E; McFarland J; McCullough J; Rodey G; Schiffer CA; Woodson R
Blood; 2005 May; 105(10):4106-14. PubMed ID: 15692069
[TBL] [Abstract][Full Text] [Related]
23. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
[TBL] [Abstract][Full Text] [Related]
24. Identification of platelet refractoriness in oncohematologic patients.
Ferreira AA; Zulli R; Soares S; Castro Vd; Moraes-Souza H
Clinics (Sao Paulo); 2011; 66(1):35-40. PubMed ID: 21437433
[TBL] [Abstract][Full Text] [Related]
25. An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.
Marsh JC; Stanworth SJ; Pankhurst LA; Kallon D; Gilbertson AZ; Pigden C; Deary AJ; Mora AS; Brown J; Laing ES; Choo LL; Hodge R; Llewelyn CA; Harding K; Sage D; Mijovic A; Mufti GJ; Navarrete CV; Brown CJ
Blood; 2021 Jan; 137(3):310-322. PubMed ID: 33475737
[TBL] [Abstract][Full Text] [Related]
26. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
Gubanova MN; Ayupova RF; Zhiburt EB
Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
[TBL] [Abstract][Full Text] [Related]
27. Transfusion of platelet concentrates--clinical evaluation of two preparations.
Strindberg J; Berlin G
Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
[TBL] [Abstract][Full Text] [Related]
28. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
Xia WJ; Ye X; Tian LW; Xu XZ; Chen YK; Luo GP; Bei CH; Deng J; Santoso S; Fu YS
Transfus Med; 2010 Aug; 20(4):269-74. PubMed ID: 20136782
[TBL] [Abstract][Full Text] [Related]
29. Neonatal Thrombocytopenia: Factors Associated With the Platelet Count Increment Following Platelet Transfusion.
Christensen RD; Bahr TM; Davenport P; Sola-Visner MC; Kelley WE; Ilstrup SJ; Ohls RK
J Pediatr; 2023 Dec; 263():113666. PubMed ID: 37572863
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
31. Preparation of random donor leukocyte-poor platelets by cytapheresis.
Olthuis HP; Stienstra S; Puylaert CE; Verhagen CM; Bär BM
Transfus Sci; 1993 Apr; 14(2):195-7. PubMed ID: 10148612
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
Fagundes IS; Franz JM; Jobim MS; Arend A; Merzoni J; Cardone JM; Gil B; Sekine L; Jobim LF
Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
[TBL] [Abstract][Full Text] [Related]
33. Transfusion experience with platelet concentrates stored for 24 to 72 hours at 22 degrees C. Importance of storage time.
Lazarus HM; Herzig RH; Warm SE; Fishman DJ
Transfusion; 1982; 22(1):39-43. PubMed ID: 7064205
[TBL] [Abstract][Full Text] [Related]
34. Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components.
Saarinen UM; Kekomäki R; Siimes MA; Myllylä G
Blood; 1990 Jan; 75(2):512-7. PubMed ID: 2295005
[TBL] [Abstract][Full Text] [Related]
35. HLA-Mediated Platelet Refractoriness.
Schmidt AE; Refaai MA; Coppage M
Am J Clin Pathol; 2019 Mar; 151(4):353-363. PubMed ID: 30285067
[TBL] [Abstract][Full Text] [Related]
36. Platelet transfusion refractoriness.
Hod E; Schwartz J
Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
[TBL] [Abstract][Full Text] [Related]
37. HLA-matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening.
Kreuger AL; Mäkelburg ABU; Somers JAE; Tomson B; van de Watering LMG; van der Bom JG; van Kraaij MGJ; Weller CM
Transfusion; 2019 Nov; 59(11):3303-3307. PubMed ID: 31602653
[TBL] [Abstract][Full Text] [Related]
38. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
Friedberg RC; Donnelly SF; Mintz PD
Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
[TBL] [Abstract][Full Text] [Related]
39. Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients.
Zhang JC; Ni LH; Tu Y; Hu HX
Front Med (Lausanne); 2023; 10():983644. PubMed ID: 36936203
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
